AI in Neurology: Global Markets

Report Code: AIT018A

Publish Date: Oct 2025

Publisher: BCC Publishing

Category: AI Technology

Download Report Overview

CUSTOMIZE NOW

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for AI in neurology was valued at $563.6 million in 2024 and is estimated to increase from $705.6 million in 2025 to reach $2.5 billion by 2030, at a compound annual growth rate (CAGR) of 28.9% from 2025 through 2030.

Report Includes

  • 52 data tables and 69 additional tables
  • An overview of the global market for AI in neurology
  • In-depth analysis of global market trends, featuring historical revenue data for 2022-2024, estimated figures for 2025, and projected CAGRs through 2030
  • Evaluation of the current market size and revenue growth prospects specific to AI in neurology, accompanied by a market share analysis by product type, application, end-user industry and region
  • Analysis of current and future demand in the global neurology market, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
  • Analysis of drivers, challenges and opportunities affecting market growth
  • Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, new product pipeline, regulatory framework and reimbursement scenarios, and ESG trends of the market
  • Market share analysis of the key market participants in the neurology market, along with their research priorities, product portfolios, global rankings and competitive landscape
  • Company profiles of major players within the industry, including Siemens Healthineers AG, GE Healthcare, Koninklijke Philips N.V., Nvidia Corp., and Canon Inc.

Report Scope

The report provides an overview of the global market for AI in neurology and analyzes market trends. It includes global revenue (in $ millions) with 2024 as the base year, estimated data for 2025, and projections from 2026 to 2030. The market is segmented based on type, end-user industry and region. The regions covered in this study include North America, Europe, Asia-Pacific, the Middle East and Africa (MEA) and South America, focusing on major countries in these regions.

The report provides an in-depth analysis of the global AI in neurology market, emphasizing the major driving forces and emerging technologies shaping this evolving field. It explores how artificial intelligence (AI) transforms neurology through enhanced diagnostic capabilities, early disease detection, personalized treatment planning and remote patient monitoring for neurological conditions such as Alzheimer’s, Parkinson’s, stroke and epilepsy.

This report analyzes AI adoption and use cases in neurology, highlighting geographic trends across North America, Europe, Asia-Pacific, South America and MEA. It also examines AI disruption across industry verticals and value chain stages, while presenting market spending patterns, investment forecasts, major company expenditures and venture capital funding in AI-driven neurology technologies.

The report examines the environmental, social and corporate governance (ESG) aspects influencing the adoption and ethical use of AI in neurology, reviews recent patent filings and innovation trends that reflect technological advancements in AI-based neuroimaging, brain-computer interfaces, digital therapeutics and wearable neurological devices.

A comprehensive competitive landscape analysis ranks and evaluates the market share of major players globally, highlighting their strategic initiatives, R&D investments and technological strengths in AI neurology solutions. The report concludes with detailed company profiles of key market participants, offering insights into their product portfolios, partnerships, acquisitions and contributions to the advancement of AI in neurological healthcare.

Report Synopsis

Report Metrics Details
Base year considered 2024
Forecast period considered 2025-2030
Base year market size $563.6 million
Market size forecast $2.5 billion
Growth rate CAGR of 28.9% for the forecast period of 2025-2030
Units considered $ Millions
Segments covered Product Type, Application, Technology, End User
Regions covered North America, Europe, Asia-Pacific, South America, Middle East and Africa
Countries covered U.S., Canada, Mexico, U.K., Italy, France, Germany, Spain, the Netherlands, Poland, the Czech Republic, Hungary, Austria, Slovakia, Slovenia, China, India, Japan, South Korea, Thailand, Singapore, Taiwan, Vietnam
Key Market Drivers
  • Rising Prevalence of Neurological Disorders
  • Demand for Early Diagnosis and Precision Medicine
  • Advancements in Neuroimaging and Data Analytics
  • Support from Governments and Regulatory Agencies
Companies studied
ACTIV SURGICALAIRAMED GMBH
BRAINOMIXBRAINQ TECHNOLOGIES LTD.
CANON INC.GE HEALTHCARE
KONINKLIJKE PHILIPS N.V.MEDTRONIC
NEOSOMA INC.NEURALINK
NEUROXNVIDIA CORP.
QURE.AISIEMENS HEALTHINEERS AG
VIZ.AI INC.
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS

Frequently Asked Questions (FAQs)

The AI in neurology market is fueled by rising neurological disorders, growing demand for early diagnosis and precision medicine, rapid advances in neuroimaging and data analytics, and strong government and regulatory support.
Key challenges include workforce shortages in rural areas and LMICs, high AI integration costs, and lack of standardized validation and transparency in AI-based neurology tools.
The market is segmented based on product type, application, technology and end user and region. The AI in Neurology market is segmented by product into AI in neuro-oncology and neuroinflammatory disorders, AI in neurovascular and traumatic brain injury, AI in epilepsy and functional brain disorders, AI in spinal and movement disorders, and AI in neurodevelopmental and psychiatric conditions. By application, it covers neuroimaging analysis, electroencephalography (EEG) interpretation, clinical decision support, drug discovery and development, and other emerging uses. Based on technology, the market includes machine learning and deep learning, natural language processing (NLP), and other AI approaches. By end user, it is categorized into hospitals and clinics, diagnostic centers, and research and development centers. The market has been segmented by geographical region into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). The North American region includes the U.S., Canada and Mexico. Europe includes Germany, the U.K., Italy, France, Spain, and the Rest of Europe; Asia-Pacific includes China, Japan, India, and the Rest of Asia-Pacific. The rest of the World (RoW) includes South America, the Middle East and Africa. It includes global revenue ($ Million) for the base year 2024 and estimated data for the forecast period 2025 through 2030.
Neuroimaging analysis will dominate the AI in neurology market.
North America accounted for 47.2% share of the market in 2024.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: AI in Neurology: Global Markets164Free
Chapter- 1: Executive Summary5Free
Chapter- 2: Market Overview9Free
Chapter- 3: Market Dynamics10Free
Chapter- 4: Regulatory Landscape5Free
Chapter- 5: Emerging Technologies and Patent Analysis10Free
Chapter- 6: Market Segmentation Analysis50Free
Chapter- 7: Competitive Intelligence13Free
Chapter- 8: Environmental, Social and Governance (ESG) Perspective8Free
Chapter- 9: Appendix54Free

Related Reports

Neurology Market: A BCC Research Overview

Published - Feb 2025 | Publisher - BCC Publishing | Code - PHM215B

The global market for neurology is estimated to increase from $67.3 billion in 2024 to reach $94.8 billion by 2029, at a compound annual growth rate (CAGR) of 7.1% from 2024 through 2029.

Artificial Intelligence (AI) in Cancer

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO196B

The global market for artificial intelligence (AI) in cancer is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth rate (CAGR) of 23.1% from 2024 through 2029.

AI in Clinical and Molecular Diagnostics Market

Published - Oct 2024 | Publisher - BCC Publishing | Code - BIO261A

The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.

Artificial Intelligence (AI) in Life Sciences Market

Published - Aug 2024 | Publisher - BCC Publishing | Code - BIO255A

The global market for artificial intelligence (AI) in life sciences products was valued at $8.0 billion in 2023. The market is estimated to grow from $9.8 billion in 2024 to $33.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.9% from 2024 to 2029.

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 121

  • Summary Table: Global Market for AI in Neurology, by Region, Through 2030
  • Table 1: Benefits of Artificial Intelligence (AI) in Neurology
  • Table 2: The Neurologist’s AI Armamentarium
  • Table 3: FDA Cleared Some Neuroimaging AI Products
  • Table 4: Porter’s Five Forces: Rating Scale
  • Table 5: Ten Neurological Conditions that Accounted for the Greatest DALYs in 2021
  • Table 6: FDA Cleared AI Algorithms, by Specialty, as of May 30, 2025
  • Table 7: Progressive Reduction of General Neurologists, 2014–2023
  • Table 8: Comparison Between Traditional Accuracy and AI-Based Accuracy
  • Table 9: AI‐Driven Precision Neurological Care: Emerging Tasks and Tool Descriptions
  • Table 10: Emerging Applications of AI Techniques in the Neurological Sciences
Sample Report

Recent Reports

AI Impact on Central Nervous System (CNS) Biomarkers: Technologies and Global Markets – BCC Pulse Report

Published - Jan 2026 | Publisher - BCC Publishing | Code - AIT089A

AI is beginning to transform the discovery, validation and application of central nervous system (CNS) biomarkers in clinical practice. AI accelerates biomarker development by analyzing large-scale datasets to support faster validation studies and regulatory submissions. AI also positioning CNS biomarkers not only as diagnostic tools but as intelligent, data-driven solutions that enhance clinical decision-making, patient access and healthcare efficiency in neurology.

AI Impact on Cloud Computing in Cell Biology, Genomics and Drug Development - BCC Pulse Report

Published - Jan 2026 | Publisher - BCC Publishing | Code - AIT087A

AI is reshaping cloud computing in cell biology, genomics and drug development, extending the existing potential of computational and experimental methods. AI helps address the industry's pain points, including lengthy timelines for discovery, high attrition rates during drug development, and ineffective design and execution of clinical trials. The combination of AI and cloud improves global collaboration by providing a compliant way to directly connect research institutes, biopharma companies and clinical sites.

AI Impact on Diabetes Therapeutics and Diagnostics Market - BCC Pulse Report

Published - Dec 2025 | Publisher - BCC Publishing | Code - AIT091A

This report provides an outlook of AI impact on the global diabetes therapeutics and diagnostics market. It highlights major AI adoption trends across the major geographic regions, and disruptions caused by AI in several key industry verticals.

AI Impact on Negative Pressure Wound Therapy (NPWT) Devices Market - BCC Pulse Report

Published - Dec 2025 | Publisher - BCC Publishing | Code - AIT090A

This report provides an outlook of AI impact on the negative pressure wound therapy (NPWT) devices market. It highlights major AI adoption trends across the major geographic regions, and disruptions caused by AI in several key industry verticals.

AI Impact on Genetic Modification Therapies Market - BCC Pulse Report

Published - Dec 2025 | Publisher - BCC Publishing | Code - AIT088A

AI is revolutionizing gene therapy by enabling more precise, efficient and personalized treatments. AI tools analyze large genomic datasets, identify potential gene targets and predict the outcomes of genetic modifications. It shows impressive pattern recognition, data processing and decision-making ability, especially in ML and deep learning (DL) algorithms.

Top Trending Reports

Global GLP-1 Analogues Market

Published - Dec 2025 | Publisher - BCC Publishing | Code - PHM289A

This report presents detailed information on glucagon-like peptide-1 (GLP-1) analogues. It examines market trends for GLP-1 analogues using data from 2024, estimates for 2025, and projected compound annual growth rates (CAGRs) through 2030 (the forecast period of 2025–2030). The report also covers regional markets for GLP-1 analogues. The GLP-1 analogue market is segmented by route of administration into oral and injection. By region, the market is divided into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America.

Data Center Networking Technologies: Global Markets

Published - Dec 2025 | Publisher - BCC Publishing | Code - IFT103C

The global market for data center networking technologies is expected to grow from $45.8 billion in 2025 and is projected to reach $103 billion by the end of 2030, at a compound annual growth rate (CAGR) of 17.6% during the forecast period of 2025 to 2030.

Protein Expression: Global Markets

Published - Nov 2025 | Publisher - BCC Publishing | Code - BIO165B

The global market for protein expression is estimated to grow from $4.7 billion in 2025 to reach $7.9 billion by 2030, at a compound annual growth rate (CAGR) of 10.9% from 2025 through 2030.

Biofuels: Global Markets

Published - Dec 2025 | Publisher - BCC Publishing | Code - EGY064F

The global market for biofuels is expected to grow from $150.9 billion in 2025 to reach $194.7 billion by the end of 2030, at a compound annual growth rate (CAGR) of 5.2% from 2025 through 2030.

Global Data Center Market

Published - Jul 2025 | Publisher - BCC Publishing | Code - IFT320A

The global market for data centers is expected to grow from $418.2 billion in 2025 and is projected to reach $691.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 10.6% during the forecast period of 2025 to 2030.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
AI in Neurology: Global Markets
Sample Report
AI Sentiment